. Tubulin modifying enzymes as target for the treatment oftau-related diseases. Pharmacol Ther. 2021 Feb;218:107681. Epub 2020 Sep 19 PubMed.

Recommends

Please login to recommend the paper.

Comments

No Available Comments

Make a Comment

To make a comment you must login or register.